Matthew Cullen

4.4k total citations
33 papers, 1.5k citations indexed

About

Matthew Cullen is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, Matthew Cullen has authored 33 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 15 papers in Hematology and 9 papers in Genetics. Recurrent topics in Matthew Cullen's work include Complement system in diseases (14 papers), Blood groups and transfusion (9 papers) and Acute Myeloid Leukemia Research (5 papers). Matthew Cullen is often cited by papers focused on Complement system in diseases (14 papers), Blood groups and transfusion (9 papers) and Acute Myeloid Leukemia Research (5 papers). Matthew Cullen collaborates with scholars based in United Kingdom, United States and Ireland. Matthew Cullen's co-authors include Stephen J. Richards, Peter Hillmen, Anita Hill, Claire Hall, Russell P. Rother, Modupe Elebute, Judith Marsh, Scott A. Rollins, Christopher F. Mojcik and Louise Arnold and has published in prestigious journals such as New England Journal of Medicine, Blood and Oncogene.

In The Last Decade

Matthew Cullen

33 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Cullen United Kingdom 14 997 583 514 484 201 33 1.5k
Kenneth Douglas United Kingdom 12 462 0.5× 423 0.7× 235 0.5× 115 0.2× 59 0.3× 23 886
Nicholas Medjeral‐Thomas United Kingdom 17 586 0.6× 283 0.5× 747 1.5× 175 0.4× 141 0.7× 23 1.1k
Radovan Sašo United Kingdom 22 311 0.3× 846 1.5× 86 0.2× 168 0.3× 278 1.4× 50 1.2k
Satish Shanbhag United States 14 289 0.3× 337 0.6× 88 0.2× 190 0.4× 81 0.4× 37 931
Anthony Dorman Ireland 16 273 0.3× 90 0.2× 432 0.8× 52 0.1× 182 0.9× 44 787
Penelope R. A. Taylor United Kingdom 19 451 0.5× 639 1.1× 42 0.1× 190 0.4× 121 0.6× 34 1.4k
Brigitte Adams Belgium 12 343 0.3× 71 0.1× 112 0.2× 44 0.1× 92 0.5× 23 603
Jorge Vela‐Ojeda Mexico 19 259 0.3× 1.1k 1.9× 31 0.1× 668 1.4× 258 1.3× 79 1.5k
Joichi Usui Japan 18 222 0.2× 98 0.2× 431 0.8× 104 0.2× 269 1.3× 90 1.0k
Peter Duggan Canada 18 168 0.2× 841 1.4× 27 0.1× 181 0.4× 452 2.2× 106 1.4k

Countries citing papers authored by Matthew Cullen

Since Specialization
Citations

This map shows the geographic impact of Matthew Cullen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Cullen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Cullen more than expected).

Fields of papers citing papers by Matthew Cullen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Cullen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Cullen. The network helps show where Matthew Cullen may publish in the future.

Co-authorship network of co-authors of Matthew Cullen

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Cullen. A scholar is included among the top collaborators of Matthew Cullen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Cullen. Matthew Cullen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Niranjan, Vikram, Nicola Cassidy, Liam Galvin, et al.. (2022). Dancing for Health and Wellbeing: A Feasibility Study of Examining Health Impacts of Online Dancing among Pulmonary Fibrosis Patients. International Journal of Environmental Research and Public Health. 19(20). 13510–13510. 1 indexed citations
2.
Gaga, Mina, Pippa Powell, Marta Almagro, et al.. (2019). ERS Presidential Summit 2018: multimorbidities and the ageing population. ERJ Open Research. 5(3). 126–2019. 1 indexed citations
3.
Cargo, Catherine, Matthew Cullen, Paul Glover, et al.. (2019). The use of targeted sequencing and flow cytometry to identify patients with a clinically significant monocytosis. Blood. 133(12). 1325–1334. 49 indexed citations
4.
Kyle, Michele, et al.. (2015). Microglia in Glia–Neuron Co-cultures Exhibit Robust Phagocytic Activity Without Concomitant Inflammation or Cytotoxicity. Cellular and Molecular Neurobiology. 35(7). 961–975. 3 indexed citations
5.
Hill, Anita, Richard J. Kelly, Austin Kulasekararaj, et al.. (2012). Eculizumab in Paroxysmal Nocturnal Hemoglobinuria (PNH): A Report of All 153 Patients Treated in the UK. Blood. 120(21). 3472–3472. 13 indexed citations
6.
Ptasinska, Anetta, Salam A. Assi, Sally James, et al.. (2012). Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding. Leukemia. 26(8). 1829–1841. 129 indexed citations
7.
Kelly, Richard, Anita Hill, Louise Arnold, et al.. (2011). Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival. Blood. 117(25). 6786–6792. 347 indexed citations
8.
Walter, Korden, Peter N. Cockerill, Rachael Barlow, et al.. (2010). Aberrant expression of CD19 in AML with t(8;21) involves a poised chromatin structure and PAX5. Oncogene. 29(20). 2927–2937. 22 indexed citations
9.
Kelly, Richard, Anita Hill, Lindsay Mitchell, et al.. (2010). Long Term Treatment with Eculizumab In Paroxysmal Nocturnal Hemoglobinuria (PNH): Sustained Efficacy and Improved Survival. Blood. 116(21). 639–639. 3 indexed citations
10.
Baker, Julie, et al.. (2009). How safe is telenursing from home?. Collegian Journal of the Royal College of Nursing Australia. 16(3). 119–123. 12 indexed citations
11.
Richards, Stephen J., Liam Whitby, Matthew Cullen, et al.. (2008). Development and evaluation of a stabilized whole‐blood preparation as a process control material for screening of paroxysmal nocturnal hemoglobinuria by flow cytometry. Cytometry Part B Clinical Cytometry. 76B(1). 47–55. 32 indexed citations
12.
Cullen, Matthew, et al.. (2007). What part does a national health call centre play in an integrated primary care service?. PubMed. 120(1249). U2421–U2421. 1 indexed citations
13.
Hill, Anita, Philip J. Platts, Alex Smith, et al.. (2006). The Incidence and Prevalence of Paroxysmal Nocturnal Hemoglobinuria (PNH) and Survival of Patients in Yorkshire.. Blood. 108(11). 985–985. 47 indexed citations
14.
Hill, Anita, Simon H. Ridley, Dirk Eßer, et al.. (2005). Protection of erythrocytes from human complement–mediated lysis by membrane-targeted recombinant soluble CD59: a new approach to PNH therapy. Blood. 107(5). 2131–2137. 44 indexed citations
15.
Cullen, Matthew, et al.. (2005). Healthline: do primary care doctors agree with the advice?. PubMed. 118(1224). U1693–U1693. 9 indexed citations
16.
Hillmen, Peter, Claire Hall, Judith Marsh, et al.. (2004). Effect of Eculizumab on Hemolysis and Transfusion Requirements in Patients with Paroxysmal Nocturnal Hemoglobinuria. New England Journal of Medicine. 350(6). 552–559. 452 indexed citations
17.
Richards, Stephen J., et al.. (2004). Evolution of GPI-Deficient Clones Predicts Clinical Course in Paroxysmal Nocturnal Haemoglobinuria.. Blood. 104(11). 172–172. 5 indexed citations
18.
Wilson, Andrew & Matthew Cullen. (2001). The Greater Murray Accessline. Australasian Psychiatry. 9(4). 351–355. 6 indexed citations
19.
O’Byrne, Kenneth J., Neil O’Hare, E. Sweeney, P. Freyne, & Matthew Cullen. (1996). Somatostatin and somatostatin analogues in medullary thyroid carcinoma. Nuclear Medicine Communications. 17(9). 810–816. 11 indexed citations
20.
O’Byrne, Kenneth J., Derek A. Hamilton, Ivan Robinson, et al.. (1992). Imaging of medullary carcinoma of the thyroid using 111In-labelled anti-CEA monoclonal antibody fragments. Nuclear Medicine Communications. 13(3). 142–148. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenneth Douglas Breakdown of academic impact, for papers by Nicholas Medjeral‐Thomas Breakdown of academic impact, for papers by Radovan Sašo Breakdown of academic impact, for papers by Satish Shanbhag Breakdown of academic impact, for papers by Anthony Dorman Breakdown of academic impact, for papers by Penelope R. A. Taylor Breakdown of academic impact, for papers by Brigitte Adams Breakdown of academic impact, for papers by Jorge Vela‐Ojeda Breakdown of academic impact, for papers by Joichi Usui Breakdown of academic impact, for papers by Peter Duggan
Rankless by CCL
2026